Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F65A1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,857
Award facts
- Contract value 100% obligated
- $19,857.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,857.46 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with the DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2031), which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Jardiance (empagliflozin) is a diabetes medication commonly used in military and veteran healthcare systems to manage type 2 diabetes. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, leveraging its expansive IDC with DLA to fulfill specific medication requirements across multiple therapeutic domains. The non-set-aside status indicates the award was made through full and open competition, consistent with the company's established track record of competitively winning federal pharmaceutical contracts across various agencies including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F65A1?
SPE2DR26F65A1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F65A1 worth?
The government has obligated $19,857 on SPE2DR26F65A1.
Is contract SPE2DR26F65A1 an order under another contract?
Yes. SPE2DR26F65A1 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F65A1 competed?
The extent of competition for SPE2DR26F65A1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award